[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)
date : 4/2/2024
Tags: AMR
![[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20240304_AMR_01-scaled-1.jpg)
On March 4 and 5, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the Joint Japan/ UK Science and Policy Workshop which was held in Shinjuku-ku, Tokyo, Japan.
The Joint Japan/ UK Science and Policy Workshop was hosted by the National Centre for Global Health and Medicine (NCGM) and Sir Howard Dalton Centre (HDC), and the University of Warwick. The workshop gathered stakeholders from science, policy, academia, industry, and philanthropy to address how new national and international cross-sectoral partnerships might work together in a sustainable manner for future antibiotic discovery.
Session 3 (Part 1) featured speakers on the theme of “Industry-Academia Collaboration for Sustainable Capacity Building in Antibiotic Drug Discovery – Next Generation Scientists, Lessons from Past Experiences, and Future Plans.”
The lecture concluded with a panel discussion and Q&A.
Chair
UK – Annette von Delft (Centre for Medicines Discovery, Oxford University)
Japan – Yui Kohno (Health and Global Policy Institute (HGPI))
Panelists (Speaking Order)
Dave Powell (Chief Scientific Officer, LIfeArc)
Manabu Sumi (Cabinet Councillor, Cabinet Agency for Infectious Disease Crisis Management, Cabinet Secretariat)
Takuko Sawada (Director of the Board and Executive Vice President, Shionogi & Co.)
Munehiro Asally (Associate Professor, School of Life Sciences, University of Warwick)
Related Posts
-
2023-12-08
[Event Report] Joint Congress on Global Health 2023 Symposium “AMR as a Global Health Challenge” (64th Japanese Society of Tropical Medicine Conference, 38th Japanese Society of Global Health Conference, 27th Japanese Society of Travel Medicine Conference, 8th International Clinical Medicine Conference, November 24, 2023, Bunkyo City, Tokyo)
-
2023-12-08
[Event Report] Joint meeting of the 72nd East Japan Regional Meeting of the Japanese Society of Infectious Diseases and the 70th East Japan Branch Meeting of the Japanese Society of Chemotherapy Symposium “Actions against AMR and New AMR National Action Plan 2023-2027” (October 25, 2023, Bunkyo-ku, Tokyo)
-
2023-09-13
[Activity Report] Recommendations for Creating a Sustainable Innovation Ecosystem for Antimicrobial R&D (August 1, 2023)
-
2023-08-29
[Event Report] APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” (July 31, August 1, 2023, Seattle, USA)
-
2023-07-24
[In the media] “Tech-powered War on AMR” (BioSpectrum Asia Edition, July 4, 2023)
-
2023-05-12
[Activity Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
-
2023-03-09
[Activity Report] HGPI Manager Attends “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics” (February 21-22, 2023)
-
2023-01-23
[Activity Report] “AMR & JAPAN’S G7 PRESIDENCY: A Call for Pull Incentives to Drive Innovation” (December 13, 2022)
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
![[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_3rd_nominations_eyecatch_caseB_ENG_web_20260929_v0.5.jpg)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
![[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261001_Eyecatch_HGPIseminer-146th-1.png)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
![[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261016_Policy-Column-2-Blood-Disorders.png)
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)
![[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/PolicyRecommendations_IntractableAndRareDiseas.jpg)
